Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?


Por: Camprubí D, Pereira A, Rodriguez-Valero N, Almuedo A, Varo R, Casals-Pascual C, Bassat Q, Malvy D and Muñoz J

Publicada: 8 abr 2019 Ahead of Print: 8 abr 2019
Resumen:
Background: Delayed haemolysis is a frequent adverse event after treatment with artesunate (AS). Removing once-infected pitted erythrocytes by the spleen is the most accepted mechanism of haemolysis in these cases. However, an increasing number of cases with positive direct antiglobulin test (DAT) haemolysis after AS have been reported. Methods: All malaria cases seen at Hospital Clinic of Barcelona between 2015 and 2017 were retrospectively reviewed. Clinical, parasitological and laboratory data from patients treated with intravenous artesunate-specifically looking for delayed haemolysis and DAT-was collected. Results: Among the 36 severe malaria patients treated with artesunate at the hospital, 10 (27.8%) developed post-artesunate delayed haemolysis. Out of these, DAT was performed in six, being positive in four of them (at least 40%). DAT was positive only for complement-without IgG-suggesting drug-dependent immune-haemolytic anaemia of the immune-complex type. Three of the four patients were treated with corticosteroids and two also received blood transfusion, with a complete recovery. Conclusions: Drug-induced auto-immune phenomena in post-artesunate delayed haemolysis may be underreported and must be considered. The role of corticosteroids should be reassessed.

Filiaciones:
Camprubí D:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Pereira A:
 Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain

Rodriguez-Valero N:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

Almuedo A:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

 Internal Medicine Department, Hospital General de Granollers, Barcelona, Spain

:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

Casals-Pascual C:
 Microbiology Department, Hospital Clínic de Barcelona, Barcelona, Spain

Bassat Q:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

 ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain

 Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique

 Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu (University of Barcelona), Barcelona, Spain

Malvy D:
 Travel Clinics and Tropical Diseases Unit, University Hospital Center of Bordeaux, Bordeaux, France

Muñoz J:
 ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
ISSN: 14752875





MALARIA JOURNAL
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 18 Número:
Páginas: 123-123
WOS Id: 000464213500001
ID de PubMed: 30961636
imagen Green Submitted, gold

MÉTRICAS